A General Anaesthetic is a drug that produces a reversible state of unconscious with absence of pain sensation over the entire body; such agents have been described as drugs that remove the most precious human attributes ---- Conscious.
Ketamine
Brand name: KETALAR
Phencyclidine derivative
Shorting acting
Mainly used in children and elderly adults for short procedures such as burns dressing.
ABUSIVE DRUG
Is a dissociative anaesthetic as it produces a cataleptic state in which the patient appears to be awake but is detached from the environment and is unresponsive to pain.
Please also refer to other reference books for clarity.
2. Overview
• A General Anaesthetic is a drug that produces a
reversible state of unconscious with absence of
pain sensation over the entire body; such agents
have been described as drugs that remove the
most precious human attributes ---- Conscious.
• For a drug to be useful as a general anaesthetic, its
actions must be of rapid onset.
3. Intravenous Anaesthetics
• Used for induction or maintenance of general
anaesthesia, sedation and to induce amnesia.
Major
Groups
Barbiturates Thiopental
Non-
Barbiturates
KETAMINE
Propofol
4. Ketamine
• Brand name: KETALAR
• Phencyclidine derivative
• Shorting acting
• Mainly used in children and
elderly adults for short
procedures such as burns
dressing.
• ABUSIVE DRUG
6. • Is a dissociative anaesthetic as it produces a
cataleptic state in which the patient appears to be
awake but is detached from the environment and
is unresponsive to pain.
• Ketamine is frequently described as a "unique
drug" because it has hypnotic, analgesic and
amnesic effects - no other drug used in clinical
practice combines these three important features.
7. Pharmacokinetics
Given IV or IM therefore:
• Rapid onset of action: 30 to 60 sec.
Distribution
Initially is distributed to highly perfused tissues
such as brain.
Extreme lipid solubility ensures its rapid transfer
across the BBB.
• Volume of distribution: 2.5-3.5 lit/kg
8. Metabolism
Hepatic microsomal enzymes cytochrome P450
by N-demethylation to form nor ketamine
which is hydroxylated and conjugated to water
soluble glucuronide derivatives and excreted
in urine.
10. Mode of Action (PD)
• Antagonises N-methyl-
D- aspartate (NMDA)
receptors; also interacts
with muscarinic
receptor, descending
monoaminergic pain
pathways, voltage-
sensitive calcium
channels and opioid
receptors in brain and
spinal cord.
11. Clinical Uses
• Sedation
• Amnesia
• Immobility
• Analgesic
• Loss of consciousness
• Pain relief in post
operative care (instead
of morphine)
12. Effect on Body System
Cardiovascular
• Stimulates sympathetic flow, causing
stimulation of heart with increased BP and CO.
• The heart rate is increased by about 20% - the
overall effect is therefore to increase the
workload of the heart.
(Contraindicated in hypertensive or stroke
patient)
14. CNS
Lipophilic drug therefore
enters CNS quickly.
This causes hallucinations,
sedations.
Good analgesic effect.
• Potent cerebral
vasodilator & capable of
increasing cerebral blood
flow by 60% in normal
individual
15. Dosage
• Same doses are used for adults and children.
Induction
IV, 1-4.5mg/kg
IM, 6.5- 12mg/kg
Drug Interaction
Atracurium + Ketamine (will reduce dose of
atracurium)
used for skeletal muscle
relaxation in anaesthesia and intensive care.
18. Reference
• Australian medicines handbook 2016 (2016) 2016th edn.
Australia: Australian Medicines Handbook Pty.
• Knights, K. and Miners, J.O. (2015) Pharmacology for health
professionals Workbook. 4th edn. Australia: Harcourt
Publishers Group (Australia) Pty.
• Whalen, K. and Pharmacology (2014) Lippincott illustrated
reviews: Pharmacology. Edited by Richard A. Harvery. 6th
edn. United States: Lippincott Williams and Wilkins.
• EPSVideoOnline (2014) Club drugs: Ketamine. Available at:
https://www.youtube.com/watch?v=z92LTc1ZX40
(Accessed: 5 May 2016).